Erlotinib
Back to searchMolecule Structure
Scientific Name
Erlotinib
Description of the Drug
Erlotinib is an EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00530
http://www.drugbank.ca/drugs/DB00530
Brand Name(s)
Tarceva
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Msn Laboratories Private Ltd, Apotex Inc, Alembic Pharmaceuticals Ltd, Osi Pharmaceuticals Llc, Sun Pharmaceutical Industries Ltd, Shilpa Medicare Ltd, Natco Pharma Ltd, Eugia Pharma Specialities Ltd, Accord Healthcare Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Epidermal growth factor receptor erbB1 | SINGLE PROTEIN | INHIBITOR | CHEMBL203 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL8413 | ||
PharmGKB | PA134687924 | ||
Human Metabolome Database | HMDB0014671 | ||
DrugBank | DB00530 | ||
PubChem: Thomson Pharma | 14878691 | ||
PubChem | 176870 | ||
Mcule | MCULE-7764565391 | ||
LINCS | LSM-1097 | ||
Nikkaji | J910.423B | ||
PDBe | AQ4 | ||
BindingDB | 5446 | ||
EPA CompTox Dashboard | DTXSID8046454 | ||
DrugCentral | 1045 | ||
Brenda | 6877 | 127378 | 50296 |
ChemicalBook | CB9285914 | ||
Guide to Pharmacology | 4920 | ||
rxnorm | ERLOTINIB | TARCEVA | ERLOTINIB HYDROCHLORIDE |
ChEBI | 114785 | ||
ZINC | ZINC000001546066 |